Veradermics, Incorporated (NYSE:MANE – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the seven ratings firms that are presently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, one has issued a hold rating and five have given a buy rating to the company. The average 12 month target price among brokers that have issued a report on the stock in the last year is $109.00.
A number of equities research analysts have issued reports on MANE shares. Cantor Fitzgerald began coverage on shares of Veradermics in a research note on Monday, March 2nd. They set an “overweight” rating on the stock. Wall Street Zen downgraded shares of Veradermics from a “hold” rating to a “sell” rating in a research note on Saturday, June 6th. Leerink Partners raised their price target on shares of Veradermics from $75.00 to $90.00 and gave the company an “outperform” rating in a research note on Wednesday, April 22nd. Weiss Ratings began coverage on shares of Veradermics in a research note on Tuesday, May 26th. They issued a “sell (d+)” rating on the stock. Finally, Citigroup raised their price target on shares of Veradermics from $120.00 to $135.00 and gave the company a “buy” rating in a research note on Monday, May 18th.
View Our Latest Stock Analysis on MANE
Veradermics Stock Performance
Veradermics (NYSE:MANE – Get Free Report) last announced its quarterly earnings data on Tuesday, May 12th. The company reported ($1.32) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.56) by ($0.76).
Veradermics Company Profile
MANE is a global manufacturer and supplier of flavors, fragrances and ingredients for the food, beverage, personal care, household and fine fragrance markets. Headquartered in France, the company develops and produces aromatic solutions that are used by consumer goods companies, food processors, perfumers and formulators seeking sensory impact, taste modulation and olfactory character for their products.
The company’s product portfolio includes savory and sweet flavor systems, beverage concentrates, natural extracts, essential oils, fragrance compounds, cosmetic ingredients and specialty functional solutions such as taste enhancers and odor masking agents.
Featured Stories
- Five stocks we like better than Veradermics
- SpaceX Rings the Bell and Shatters Every Record
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
- 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
- The 127-Gigawatt Problem: Why AI Needs Its Own Power
Receive News & Ratings for Veradermics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradermics and related companies with MarketBeat.com's FREE daily email newsletter.
